I now have all the key information needed for a comprehensive answer. Let me compile it.
PRES in Eclampsia (Posterior Reversible Encephalopathy Syndrome)
Definition & Overview
PRES (also known as reversible posterior leukoencephalopathy syndrome, RPLS) is a clinico-radiological syndrome of vasogenic cerebral edema that is a well-recognized complication of preeclampsia-eclampsia. It results from vascular endothelial dysfunction and breakdown of cerebral autoregulation.
"PRES is thought to be due to abnormal cerebral vascular autoregulation resulting in vasogenic edema." — Bradley and Daroff's Neurology in Clinical Practice
Pathophysiology
There are two interrelated mechanisms:
1. Loss of Cerebral Autoregulation (Hyperperfusion Theory)
- Severe, sudden hypertension overwhelms the brain's ability to autoregulate blood flow
- Forced vasodilation → hyperperfusion → fluid extravasation into the interstitium
- Results in vasogenic edema — predominantly in posterior (parieto-occipital) white matter
- The posterior circulation is more susceptible because it has less adrenergic innervation
2. Endothelial Dysfunction (Vasospasm Theory)
- In eclampsia, circulating anti-angiogenic factors (e.g., sFlt-1) and endothelial activation cause endothelial injury
- Damage to capillary endothelial tight junctions → fluid extravasation
- Vasodilatation and vasogenic edema occur
- This is analogous to the mechanism seen with calcineurin inhibitors (tacrolimus, cyclosporine)
Clinical Features (Classic Tetrad)
| Feature | Detail |
|---|
| Headache | Severe, diffuse — most common symptom |
| Visual disturbances | Blurring, visual field defects, cortical blindness (due to occipital involvement) |
| Seizures | Often generalized tonic-clonic; hallmark of eclampsia |
| Altered consciousness | Confusion → encephalopathy → coma in severe cases |
"Cortical visual deficits can occasionally be the presenting feature, others including headache and seizures." — Kanski's Clinical Ophthalmology
MRI Findings
PRES has a characteristic and diagnostic MRI appearance:
- Modality of choice: MRI with FLAIR sequence
- Signal: T2/FLAIR hyperintensities (vasogenic edema) — hypointense on T1
- Location: Predominantly parietal and occipital lobe white matter, bilateral and roughly symmetric
- Gray matter (cortex, basal ganglia) can also be involved
- Frontal and temporal lobes may be affected in atypical/severe cases
- DWI: Typically shows no diffusion restriction (distinguishing vasogenic from cytotoxic/ischemic edema) — though areas of true infarction may show restriction in severe cases
T2/FLAIR axial MRI: bilateral hyperintensities in parieto-occipital regions representing vasogenic edema in a patient with preeclampsia/eclampsia. Yellow arrows indicate the characteristic posterior distribution.
Axial FLAIR: hyperintense signal in bilateral occipital subcortical white matter (left > right) in a patient presenting with hypertension, visual changes, and seizure.
Follow-up MRI 1 month after treatment for PRES associated with eclampsia and HELLP syndrome — complete radiological resolution, demonstrating the "reversible" nature of the condition.
Diagnosis
- Clinical + MRI confirmation
- CT may show cerebral edema but is less sensitive than MRI
- Lumbar puncture: not routinely required; may show elevated opening pressure
- Blood work: assess for HELLP (CBC, LFTs, LDH), renal function, proteinuria
- Exclude stroke (DWI positive) and other encephalopathies
Association with Eclampsia
- PRES is found in a significant proportion of women with severe preeclampsia and eclampsia
- The pathophysiology overlaps: both involve endothelial dysfunction and disrupted cerebral autoregulation
- Postpartum eclampsia accounts for ~25% of eclamptic seizures and can occur up to 8 weeks postpartum, even without preceding hypertension — PRES must be considered in this window
- Long-term: women with preeclampsia have more white matter lesions and are more likely to report cognitive dysfunction compared to normotensive pregnancies
- Severe cases can progress to cytotoxic edema and infarction (irreversible injury)
Management
Definitive Treatment
Delivery of the fetus (and placenta) is the only cure for eclampsia-associated PRES.
Seizure Control
| Drug | Role |
|---|
| Magnesium sulfate | Drug of choice — more effective than phenytoin in preventing recurrence; reduces maternal death; benefits the neonate (fewer NICU admissions) |
| Benzodiazepines | Acute seizure termination if actively seizing |
| Phenytoin/levetiracetam | Second-line; used if Mg contraindicated |
"Magnesium is the therapy of choice to treat acute eclamptic seizures and prevent recurrence. It is more effective and has a better safety profile than phenytoin." — Rosen's Emergency Medicine
Blood Pressure Control
- Target: reduce BP by no more than 25% in the first hour, then gradually to ~160/105 mmHg
- Agents: labetalol (IV), hydralazine (IV), nifedipine (oral)
- Avoid nitroprusside in pregnancy (fetal cyanide toxicity)
General Supportive Care
- Airway management, O₂ supplementation
- Continuous fetal monitoring (>24 weeks)
- ICU-level monitoring in severe cases
Prognosis & Reversibility
- With prompt treatment, imaging and clinical findings typically resolve (the "R" in PRES)
- Irreversible infarction can occur if treatment is delayed or hypertension is extreme
- The name changed from "reversible posterior leukoencephalopathy" because gray matter involvement and frontal/temporal extension are recognized
Differential Diagnosis
| Condition | Key Distinction |
|---|
| Ischemic stroke | DWI positive (restricted diffusion), not bilateral/symmetric |
| Cerebral venous thrombosis | Venous phase CTA/MRV; often frontal/parasagittal; prothrombotic setting |
| Hypertensive encephalopathy (non-obstetric) | Similar imaging; no pregnancy context |
| Herpes encephalitis | Temporal lobe predominant; CSF PCR positive |
| ADEM | White matter lesions with different distribution; often post-infectious |
Sources:
- Creasy & Resnik's Maternal-Fetal Medicine, 8th ed. — Chapter 45
- Bradley and Daroff's Neurology in Clinical Practice — Chapter 40
- Rosen's Emergency Medicine — Chapter 88
- Kanski's Clinical Ophthalmology, 10th ed. — Chapter on neuro-ophthalmology